INTERNATIONAL PATENT: NUMAB THERAPEUTICS AG FILES APPLICATION FOR "ANTIBODY BINDING DOMAINS HAVING SPECIFICITY FOR LILRB2"

GENEVA, July 2 -- NUMAB THERAPEUTICS AG (Bachtobelstrasse 58810 Horgen) filed a patent application (PCT/EP2024/088372) for "ANTIBODY BINDING DOMAINS HAVING SPECIFICITY FOR LILRB2" on Dec 23, 2024. With publication no. WO/2025/133389, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): TRUB, Marta (Gotenstrasse 804125 Riehen), GUNDE, Tea (Turbinenstrasse 338005 Zurich), SNELL, Daniel (Gotthardstrasse 98800 Thalwil), WARMUTH, Stefan (Zopftstrasse 288804 Au), BROCK, Matthias (Feldstrasse 468904 Aesch), HESS, Christian (Doltschih...